Loading...

You're on the old version of Simply Wall St. We will no longer be supporting this site, so we recommend you switch to our brand new platform.

MTBC

DB:MTB
Snowflake Description

Flawless balance sheet and fair value.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
MTB
DB
$68M
Market Cap
  1. Home
  2. DE
  3. Healthcare
Company description

MTBC, Inc., a healthcare information technology company, provides an integrated suite of Web-based solutions and related business services to healthcare providers primarily in the United States. The last earnings update was 40 days ago. More info.


Add to Portfolio Compare Print
  • MTBC has significant price volatility in the past 3 months.
MTB Share Price and Events
7 Day Returns
1.2%
DB:MTB
10.8%
DE Healthcare Services
4.3%
DE Market
1 Year Returns
17.7%
DB:MTB
14.2%
DE Healthcare Services
-14.2%
DE Market
MTB Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
MTBC (MTB) 1.2% 10.2% 32.6% 17.7% - -
DE Healthcare Services 10.8% 3% -3.8% 14.2% 47.1% 117.7%
DE Market 4.3% -9% -21.6% -14.2% -19.6% -25.6%
1 Year Return vs Industry and Market
  • MTB outperformed the Healthcare Services industry which returned 14.2% over the past year.
  • MTB outperformed the Market in Germany which returned -14.2% over the past year.
Price Volatility
MTB
Industry
5yr Volatility vs Market

Value

 Is MTBC undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of MTBC to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for MTBC.

DB:MTB Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 5 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 4.4%
Perpetual Growth Rate 10-Year DE Government Bond Rate -0.4%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for DB:MTB
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year DE Govt Bond Rate -0.4%
Equity Risk Premium S&P Global 5.4%
Healthcare Services Unlevered Beta Simply Wall St/ S&P Global 0.79
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.79 (1 + (1- 21%) (6.02%))
0.885
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.88
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= -0.39% + (0.885 * 5.44%)
4.42%

Discounted Cash Flow Calculation for DB:MTB using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for MTBC is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

Note: Free cash flow to equity valuations ignore the company's cash or debt.

DB:MTB DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (USD, Millions) Source Present Value
Discounted (@ 4.42%)
2020 9.27 Analyst x1 8.87
2021 14.53 Analyst x1 13.32
2022 18.14 Est @ 24.85% 15.93
2023 21.27 Est @ 17.28% 17.89
2024 23.82 Est @ 11.98% 19.18
2025 25.79 Est @ 8.27% 19.89
2026 27.25 Est @ 5.67% 20.13
2027 28.30 Est @ 3.85% 20.02
2028 29.03 Est @ 2.58% 19.66
2029 29.52 Est @ 1.69% 19.15
Present value of next 10 years cash flows $174.00
DB:MTB DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2029 × (1 + g) ÷ (Discount Rate – g)
= $29.52 × (1 + -0.39%) ÷ (4.42% – -0.39%)
$611.02
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= $611.02 ÷ (1 + 4.42%)10
$396.40
DB:MTB Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= $174.00 + $396.40
$570.40
Equity Value per Share
(USD)
= Total value / Shares Outstanding
= $570.40 / 12.36
$46.13
DB:MTB Discount to Share Price
Calculation Result
Non-primary Listing Adjustment Factor 1 share in DB:MTB represents 0.90182x of NasdaqGM:MTBC
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
0.90182x
Value per Share
(Listing Adjusted, EUR)
= Value per Share (USD) x Listing Adjustment Factor
= $ 46.13 x 0.90182
€41.60
Value per share (EUR) From above. €41.60
Current discount Discount to share price of €4.96
= -1 x (€4.96 - €41.60) / €41.60
88.1%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price MTBC is available for.
Intrinsic value
>50%
Share price is €4.96 vs Future cash flow value of €41.6
Current Discount Checks
For MTBC to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • MTBC's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • MTBC's share price is below the future cash flow value, and at a substantial discount (> 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for MTBC's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are MTBC's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
DB:MTB PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-12-31) in USD $-0.60
NasdaqGM:MTBC Share Price ** NasdaqGM (2020-04-07) in USD $5.5
Germany Healthcare Services Industry PE Ratio Median Figure of 6 Publicly-Listed Healthcare Services Companies 11.55x
Germany Market PE Ratio Median Figure of 402 Publicly-Listed Companies 17.07x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of MTBC.

DB:MTB PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NasdaqGM:MTBC Share Price ÷ EPS (both in USD)

= 5.5 ÷ -0.60

-9.16x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • MTBC is loss making, we can't compare its value to the DE Healthcare Services industry average.
  • MTBC is loss making, we can't compare the value of its earnings to the Germany market.
Price based on expected Growth
Does MTBC's expected growth come at a high price?
Raw Data
DB:MTB PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -9.16x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 5 Analysts
10%per year
Europe Healthcare Services Industry PEG Ratio Median Figure of 14 Publicly-Listed Healthcare Services Companies 2.67x
Germany Market PEG Ratio Median Figure of 256 Publicly-Listed Companies 1.24x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for MTBC, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on MTBC's assets?
Raw Data
DB:MTB PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-12-31) in USD $3.50
NasdaqGM:MTBC Share Price * NasdaqGM (2020-04-07) in USD $5.5
Germany Healthcare Services Industry PB Ratio Median Figure of 7 Publicly-Listed Healthcare Services Companies 2.86x
Germany Market PB Ratio Median Figure of 573 Publicly-Listed Companies 1.47x
DB:MTB PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NasdaqGM:MTBC Share Price ÷ Book Value per Share (both in USD)

= 5.5 ÷ 3.50

1.57x

* Primary Listing of MTBC.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • MTBC is good value based on assets compared to the DE Healthcare Services industry average.
X
Value checks
We assess MTBC's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare Services industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare Services industry average (and greater than 0)? (1 check)
  5. MTBC has a total score of 3/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is MTBC expected to perform in the next 1 to 3 years based on estimates from 5 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
10%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is MTBC expected to grow at an attractive rate?
  • Unable to compare MTBC's earnings growth to the low risk savings rate as it is expected to be loss making during the next 1-3 years.
Growth vs Market Checks
  • Unable to compare MTBC's earnings growth to the Germany market average as it is expected to be loss making during the next 1-3 years.
  • MTBC's revenue growth is expected to exceed the Germany market average.
Annual Growth Rates Comparison
Raw Data
DB:MTB Future Growth Rates Data Sources
Data Point Source Value (per year)
DB:MTB Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 5 Analysts 10%
DB:MTB Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 5 Analysts 23.7%
Europe Healthcare Services Industry Earnings Growth Rate Market Cap Weighted Average 26.9%
Europe Healthcare Services Industry Revenue Growth Rate Market Cap Weighted Average 8%
Germany Market Earnings Growth Rate Market Cap Weighted Average 14.1%
Germany Market Revenue Growth Rate Market Cap Weighted Average 3.9%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
DB:MTB Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 5 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
DB:MTB Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2021-12-31 106 17 -5 4
2020-12-31 100 12 -15 5
2020-04-08
DB:MTB Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-12-31 64 8 -7
2019-09-30 65 7 -8
2019-06-30 65 8 -9
2019-03-31 57 7 -8
2018-12-31 51 7 -7
2018-09-30 42 6 -6
2018-06-30 33 3 -4
2018-03-31 32 2 -5
2017-12-31 32 0 -8
2017-09-30 32 -2 -11
2017-06-30 30 -1 -11
2017-03-31 28 -1 -10

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • MTBC is not considered high growth as it is expected to be loss making for the next 1-3 years.
  • MTBC's revenue is expected to grow significantly at over 20% yearly.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
DB:MTB Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 5 Analyst Estimates (S&P Global) See Below

All data from MTBC Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:MTB Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2021-12-31 -0.38 0.07 -0.73 4.00
2020-12-31 -1.00 -0.14 -2.38 5.00
2020-04-08
DB:MTB Past Financials Data
Date (Data in USD Millions) EPS *
2019-12-31 -0.60
2019-09-30 -0.68
2019-06-30 -0.78
2019-03-31 -0.68
2018-12-31 -0.59
2018-09-30 -0.48
2018-06-30 -0.37
2018-03-31 -0.47
2017-12-31 -0.69
2017-09-30 -1.02
2017-06-30 -1.07
2017-03-31 -1.03

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if MTBC will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess MTBC's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Europe market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Europe market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
MTBC has a total score of 2/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has MTBC performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare MTBC's growth in the last year to its industry (Healthcare Services).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • MTBC does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare MTBC's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare MTBC's 1-year growth to the DE Healthcare Services industry average as it is not currently profitable.
Earnings and Revenue History
MTBC's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from MTBC Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:MTB Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-12-31 64.44 -7.26 19.31 0.87
2019-09-30 65.19 -8.11 20.52 0.91
2019-06-30 65.39 -9.25 21.32 1.00
2019-03-31 57.32 -8.05 19.25 1.03
2018-12-31 50.55 -6.96 17.63 1.03
2018-09-30 42.33 -5.57 15.68 1.01
2018-06-30 32.80 -4.32 12.79 0.99
2018-03-31 31.90 -5.39 12.38 1.06
2017-12-31 31.81 -7.60 12.81 1.08
2017-09-30 32.35 -10.89 13.28 1.17
2017-06-30 30.18 -10.98 13.42 1.10
2017-03-31 27.60 -10.32 13.30 0.99
2016-12-31 24.49 -9.55 13.21 0.90
2016-09-30 21.03 -6.33 11.61 0.74
2016-06-30 21.30 -5.84 11.92 0.73
2016-03-31 22.05 -5.87 12.28 0.69
2015-12-31 23.08 -4.89 12.29 0.66
2015-09-30 24.82 -4.88 12.57 0.62
2015-06-30 25.22 -6.49 13.18 0.62
2015-03-31 21.87 -5.29 11.43 0.58
2014-12-31 18.30 -4.51 9.49 0.53
2014-09-30 14.18 -3.42 7.83 0.49
2014-06-30 11.12 -0.78 5.41 0.43
2014-03-31 10.81 -0.58 5.00 0.41
2013-12-31 10.47 -0.18 4.71 0.39
2013-09-30 9.91 -0.21 4.61 0.39

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if MTBC has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if MTBC has efficiently used its assets last year compared to the DE Healthcare Services industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if MTBC improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess MTBC's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare Services industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
MTBC has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is MTBC's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up MTBC's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • MTBC is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • MTBC's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of MTBC's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is covered by short term assets, assets are 84.5x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from MTBC Company Filings, last reported 3 months ago.

DB:MTB Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-12-31 42.84 0.37 19.99
2019-09-30 37.42 0.51 13.99
2019-06-30 34.41 0.31 10.58
2019-03-31 37.01 0.39 12.53
2018-12-31 38.87 0.50 14.47
2018-09-30 27.27 0.64 1.26
2018-06-30 29.12 0.22 11.72
2018-03-31 20.68 0.20 3.54
2017-12-31 20.25 0.29 4.36
2017-09-30 16.57 2.38 2.79
2017-06-30 11.28 9.89 5.81
2017-03-31 4.23 13.34 1.25
2016-12-31 7.07 14.05 3.48
2016-09-30 11.07 9.85 7.11
2016-06-30 11.35 9.74 6.62
2016-03-31 12.82 9.79 7.37
2015-12-31 14.89 7.98 8.04
2015-09-30 10.58 5.75 1.61
2015-06-30 11.66 3.66 0.63
2015-03-31 13.10 3.83 1.19
2014-12-31 14.32 2.33 1.05
2014-09-30 15.13 2.53 2.49
2014-06-30 -0.38 3.22 0.03
2014-03-31 24.12 2.99 5.59
2013-12-31 0.12 3.56 0.50
2013-09-30 0.02 4.27 0.93
  • MTBC's level of debt (0.9%) compared to net worth is satisfactory (less than 40%).
  • The level of debt compared to net worth has been reduced over the past 5 years (16.3% vs 0.9% today).
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Whilst loss making MTBC has sufficient cash runway for more than 3 years if it maintains the current positive free cash flow level.
  • Whilst loss making MTBC has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by -48.7% per year.
X
Financial health checks
We assess MTBC's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. MTBC has a total score of 6/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is MTBC's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from MTBC dividends.
If you bought €2,000 of MTBC shares you are expected to receive €0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate MTBC's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate MTBC's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
DB:MTB Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 5 Analyst Estimates (S&P Global) See Below
Europe Healthcare Services Industry Average Dividend Yield Market Cap Weighted Average of 10 Stocks 1.4%
Germany Market Average Dividend Yield Market Cap Weighted Average of 314 Stocks 3.6%
Germany Minimum Threshold Dividend Yield 10th Percentile 0.8%
Germany Bottom 25% Dividend Yield 25th Percentile 1.6%
Germany Top 25% Dividend Yield 75th Percentile 4.6%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

DB:MTB Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2021-12-31
2020-12-31
2020-04-08

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as MTBC has not reported any payouts.
  • Unable to verify if MTBC's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of MTBC's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as MTBC has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess MTBC's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can MTBC afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. MTBC has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of MTBC's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Stephen Snyder
COMPENSATION $1,145,180
AGE 42
TENURE AS CEO 2.3 years
CEO Bio

Mr. Stephen A. Snyder has been Chief Executive Officer of MTBC Inc. since January 2018. Mr. Snyder serves as Director at CareCloud Corporation since 2020. Mr. Snyder served as the President of MTBC Inc. since September 2011 to January 1, 2018. Mr. Snyder served as the Chief Operating Officer of Medical Transcription Billing, Corp from January 2009 to August 2011. Mr. Snyder joined MTBC Inc. in September 2005 as a Vice President and General Counsel. Mr. Snyder served as an attorney with a New Jersey law firm. He has been a Director at MTBC Inc. since 2013. He is a member of the New Jersey and New York bars, the American Health Lawyers Association and the American Trial Lawyers Association and his writings on healthcare law and practice management have been published in print and electronic media by the American Health Lawyers Association, American Bar Association and various industry publications. Mr. Snyder received his Bachelor of Arts in Political Science magna cum laude from Montclair State University and received his Juris Doctorate from Rutgers School of Law - Newark, where he served as a senior editor of a law journal.

CEO Compensation
  • Stephen's compensation has increased whilst company is loss making.
  • Stephen's remuneration is higher than average for companies of similar size in Germany.
Management Team Tenure

Average tenure and age of the MTBC management team in years:

1.9
Average Tenure
42
Average Age
  • The average tenure for the MTBC management team is less than 2 years, this suggests a new team.
Management Team

Stephen Snyder

TITLE
CEO & Director
COMPENSATION
$1M
AGE
42
TENURE
2.3 yrs

A. Chaudhry

TITLE
President & Director
COMPENSATION
$704K
AGE
42
TENURE
2.3 yrs

Bill Korn

TITLE
Chief Financial Officer
COMPENSATION
$862K
AGE
62
TENURE
6.8 yrs

Norman Roth

TITLE
Principal Accounting Officer & Controller
AGE
63

Shruti Patel

TITLE
President of Telehealth Division & Director of Compliance
AGE
31
TENURE
0.2 yrs

Kim Grant

TITLE
General Counsel
AGE
34
TENURE
1.5 yrs

Wes Stolp

TITLE
Executive Vice President of Sales

Mike Cuesta

TITLE
Chief Marketing Officer

Loraine Goetsch

TITLE
Division President

Jon Bertman

TITLE
Chief Medical Officer
TENURE
0.6 yrs
Board of Directors Tenure

Average tenure and age of the MTBC board of directors in years:

6.3
Average Tenure
65
Average Age
  • The tenure for the MTBC board of directors is about average.
Board of Directors

Mahmud Haq

TITLE
Founder & Executive Chairman
COMPENSATION
$1M
AGE
60
TENURE
19.3 yrs

Stephen Snyder

TITLE
CEO & Director
COMPENSATION
$1M
AGE
42
TENURE
7.3 yrs

Howard Clark

TITLE
Independent Vice Chairman
COMPENSATION
$201K
AGE
75
TENURE
1 yrs

A. Chaudhry

TITLE
President & Director
COMPENSATION
$704K
AGE
42
TENURE
1 yrs

Cameron Munter

TITLE
Independent Director
COMPENSATION
$191K
AGE
65
TENURE
6.8 yrs

John Daly

TITLE
Independent Director
COMPENSATION
$191K
AGE
81
TENURE
6.3 yrs

Anne Busquet

TITLE
Independent Director
COMPENSATION
$191K
AGE
69
TENURE
5.8 yrs
Who owns this company?
Recent Insider Trading
  • MTBC individual insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
27. Mar 20 Sell John Daly Individual 25. Mar 20 25. Mar 20 -10,000 €5.09 €-50,944
04. Mar 20 Sell Mahmud Haq Individual 03. Mar 20 04. Mar 20 -132,729 €4.58 €-607,161
06. Mar 20 Sell John Daly Individual 06. Mar 20 06. Mar 20 -3,500 €4.87 €-17,031
06. Mar 20 Sell Mahmud Haq Individual 05. Mar 20 05. Mar 20 -117,271 €4.63 €-543,073
04. Mar 20 Sell Kimberly Grant Individual 02. Mar 20 02. Mar 20 -5,525 €4.76 €-26,316
04. Mar 20 Sell John Daly Individual 02. Mar 20 02. Mar 20 -6,467 €4.89 €-31,615
04. Mar 20 Sell Shruti Patel Individual 02. Mar 20 02. Mar 20 -11,375 €4.77 €-54,282
15. Nov 19 Sell A. Chaudhry Individual 13. Nov 19 14. Nov 19 -5,000 €3.43 €-17,109
08. Nov 19 Sell John Daly Individual 07. Nov 19 07. Nov 19 -10,000 €3.23 €-32,323
01. Oct 19 Sell John Daly Individual 27. Sep 19 30. Sep 19 -5,000 €3.58 €-17,853
17. Aug 19 Sell John Daly Individual 15. Aug 19 16. Aug 19 -8,000 €4.19 €-33,344
15. Aug 19 Sell John Daly Individual 12. Aug 19 12. Aug 19 -2,000 €4.19 €-8,374
08. Jun 19 Sell A. Chaudhry Individual 06. Jun 19 07. Jun 19 -4,000 €4.12 €-16,476
01. Jun 19 Sell John Daly Individual 29. May 19 30. May 19 -6,600 €4.40 €-28,955
X
Management checks
We assess MTBC's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. MTBC has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Company Info

Description

MTBC, Inc., a healthcare information technology company, provides an integrated suite of Web-based solutions and related business services to healthcare providers primarily in the United States. The company operates through two segments, Healthcare IT and Practice Management. It primarily offers PracticePro, a software-as-a-service platform, which includes practice management software and related tools that facilitate the day-to-day business operation and workflows; electronic health record (EHR), which enables customers to reduce paperwork; revenue cycle management services, such as end-to-end medical billing, analytics, and related services; and mobile health solutions, including smartphone applications that assist patients and healthcare providers in the provision of healthcare services. The company also provides a Web-based EHR solution; healthcare claims clearinghouse services; transcription, coding, indexing, and other ancillary services; electronic data interchange services; and talkEHR, a voice enabled EHR solution. It serves physicians, nurses, nurse practitioners, physician assistants, and other clinical staff that render bills for their services. The company was formerly known as Medical Transcription Billing, Corp. and changed its name to MTBC, Inc. in February 2019. MTBC, Inc. was founded in 1999 and is headquartered in Somerset, New Jersey.

Details
Name: MTBC, Inc.
MTB
Exchange: DB
Founded: 1999
$62,441,295
12,364,368
Website: http://www.mtbc.com
Address: MTBC, Inc.
7 Clyde Road,
Somerset,
New Jersey, 08873,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NasdaqGM MTBC Common Shares Nasdaq Global Market US USD 23. Jul 2014
DB MTB Common Shares Deutsche Boerse AG DE EUR 23. Jul 2014
NasdaqGM MTBC.P 11% CUM PFD CL A Nasdaq Global Market US USD 05. Nov 2015
Number of employees
Current staff
Staff numbers
2,700
MTBC employees.
Industry
Health Care Technology
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2020/04/08 06:01
End of day share price update: 2020/04/07 00:00
Last estimates confirmation: 2020/04/02
Last earnings filing: 2020/02/28
Last earnings reported: 2019/12/31
Last annual earnings reported: 2019/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.